MSLN and neoplasm: While lower affinity monoclonal antibodies have been found to penetrate tumors more effectively than higher affinity antibodies15, it has also been shown that RIT bound to shed mesothelin can improve tumor penetration by acting as a reservoir31, suggesting that higher affinity to shed mesothelin would increase penetration.